Fundraising Fox

BioTrace Medical

Acquired

Menlo Park, US · Founded 2013 · Delaware corporation · 2 known investors

Founders & leadership

LN
Laura N. DietchExecutive
TF
Thomas Fogarty, MDNamed on SEC filing
KS
Kurt SparksNamed on SEC filing

Board

SSSharon Stevenson, DVM, PhD
Sharon Stevenson, DVM, PhDinBoard directorCo-Founder, Managing Director, Venture Partner at Okapi Venture Capital
DH
Drew HoffmannBoard director
RBRobert Brownell
Robert BrownellBoard directorManaging Director at Emergent Medical Partners, LLP
AS
Aravind Swaminathan, MDBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$21.7M disclosed across 4 rounds · 2014–2021

$10.9MraisedMar 2021 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura N, DietchExecutive Officer, Director
  • Drew HoffmannDirector
  • Aravind SwaminathanExecutive Officer, Director
  • Robert BrownellDirector
  • Sharon StevensonDirector
  • Ronald MizrahiDirector
  • Shilen PatelDirector
Offering amount
$16.3M
Amount sold
$10.9M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5.7MraisedMay 2017 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert BrownellDirector
  • Drew HoffmannDirector
  • Aravind Swaminathan, MDExecutive Officer, Director
  • Laura N. DietchExecutive Officer, Director
  • Adam HenickDirector
  • Sharon Stevenson, DVM, PhDDirector
Offering amount
$8.3M
Amount sold
$5.7M
Minimum investment
$1
First sale
May 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.7MraisedJul 2015 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Sharon Stevenson, DVM, PhDDirector
  • Laura N. DietchExecutive Officer, Director
  • Aravind Swaminathan, MDDirector
  • Drew HoffmannDirector
  • Robert BrownellDirector
Offering amount
$1.9M
Amount sold
$1.7M
Minimum investment
$1
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.5MraisedFeb 2014 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Aravind Swaminathan, MDExecutive Officer, Director
  • Thomas Fogarty, MDDirector
  • Sharon Stevenson, DVM, PhDDirector
  • Laura N. DietchExecutive Officer, Director
  • Kurt SparksExecutive Officer
Offering amount
$3.6M
Amount sold
$3.5M
Minimum investment
$1
First sale
Feb 2014
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are BioTrace Medical's investors?
BioTrace Medical's investors include Emergent Medical Partners, LLP, Okapi Venture Capital.
How much funding has BioTrace Medical raised?
BioTrace Medical has disclosed $21.7M raised across 4 rounds.
Where is BioTrace Medical headquartered?
BioTrace Medical is headquartered in Menlo Park, US.